Centre Oscar Lambret; Cancerologie Gynecologique
About Centre Oscar Lambret; Cancerologie Gynecologique
"Le Centre Oscar Lambret de Lille, situé dans la région des Hauts-de-France, est une référence nationale en cancérologie. Hôpital universitaire, il a trois missions principales: le soin, la recherche et l'enseignement. Le Centre Oscar Lambret, créé en 1955, fait partie du groupe UNICANCER, qui réunit les 18 Centres de Lutte Contre le Cancer, établissements de santé privés d’intérêt collectif (ESPIC) exclusivement dédiés aux soins, à la recherche et à l’enseignement en cancérologie, et participant au service public hospitalier avec des tarifs conventionnels, sans aucun dépassement d’honoraires. Le Centre a été certifié par la Haute Autorité de Santé en septembre 2018."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Clinical Trials at Centre Oscar Lambret; Cancerologie Gynecologique
During the past decade, Centre Oscar Lambret; Cancerologie Gynecologique conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
2009-10-29
2014-07-09
Completed
361
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Study of Bevacizumab (Avastin) in Neoadjuvant Therapy in Participants With International Federation of Gynecology and Obstetrics (FIGO) Stage IIIC/IV Ovarian, Tubal, or Peritoneal Cancer, Initially Unresectable
2013-02-01
2016-08-17
Completed
99
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer
2014-01-31
2021-06-04
Completed
1,846
A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer
2014-07-14
2020-08-25
Completed
401
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Oscar Lambret; Cancerologie Gynecologique"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Centre Oscar Lambret; Cancerologie Gynecologique
According to Clinical.Site data, the most researched conditions in "Centre Oscar Lambret; Cancerologie Gynecologique" are
"Breast Cancer" (3 trials) and "Ovarian Cancer" (2 trials). Many other conditions were trialed in "Centre Oscar Lambret; Cancerologie Gynecologique" in a lesser frequency.
Clinical Trials Intervention Types at Centre Oscar Lambret; Cancerologie Gynecologique
Most popular intervention types in "Centre Oscar Lambret; Cancerologie Gynecologique" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (4 trials), "5-Fluorouracil" (3 trials), "Cyclophosphamide" (3 trials), "Docetaxel" (3 trials) and "Doxorubicin" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Centre Oscar Lambret; Cancerologie Gynecologique
The vast majority of trials in "Centre Oscar Lambret; Cancerologie Gynecologique" are
3 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Centre Oscar Lambret; Cancerologie Gynecologique
Currently, there are NaN active trials in "Centre Oscar Lambret; Cancerologie Gynecologique".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Centre Oscar Lambret; Cancerologie Gynecologique,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centre Oscar Lambret; Cancerologie Gynecologique, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".